# Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)

> **NCT06928701** · NA · RECRUITING · sponsor: **University of Eastern Piedmont** · enrollment: 160 (estimated)

## Conditions studied

- Early Breast Cancer
- Neoadjuvant Treatment

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (hexadecenoic acid)

## Key facts

- **NCT ID:** NCT06928701
- **Lead sponsor:** University of Eastern Piedmont
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06928701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06928701, "Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06928701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*